Grant ID RP160657
Awarded On May 18, 2016
Title Targeted Therapeutic Drug Discovery & Development Program
Program Academic Research
Award Mechanism Core Facility Support Awards
Institution/Organization The University of Texas at Austin
Principal Investigator/Program Director Kevin N Dalby
Cancer Sites All Sites
Contracted Amount $4,982,636
Lay Summary

With the growing appreciation of the molecular pathways underlying different cancers, the new approach of cancer therapeutics is to target specific pathways so that ultimately, we may create rationally-developed combinatorial strategies that circumvent drug resistance. While cancer researchers have identified many clinically important cancer-related targets, the critical challenge in advancing new molecules from ‘discovery’ to pre-clinical testing is lack of access to the specialized resources and multi-disciplinary experiences that are necessary to support the early phase of drug development effort. The goal of the GCC High Throughput Screening Program has been to provide Texas’ researchers...

Read More